Folsäure bei Hyperhomocysteinämie?

Literatur

• 1 Boushey C J, Beresford S A, Omen G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acids intakes.  JAMA. 1995;  274 1049-1057
• 2 Hankey G J, Eikelboom J W, Khoon Ho W, Bockxmeer F M. Clinical usefulness of plasma homocysteine in vascular disease.  Med J Aust. 2004;  181 314-318
• 3 Lange H, Suryapranata H, De Luca G, Börner C. et al . Folate therapy and in-stent restenosis after coronary stenting.  N Engl J Med. 2004;  350 2673-2681
• 4 Schnyder G, Roffi M, Pin R. et al . Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.  N Engl J Med. 2001;  345 1594-1600
• 5 Toole J F, Malinow M R, Chambless L E, Spence J D. et al . Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.  JAMA. 2004;  291 565-575